cimetidine has been researched along with ebrotidine in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 5 (71.43) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (28.57) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, M; Fang, H; Liu, Z; Shi, Q; Tong, W; Vijay, V | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Gómez, F; Ortíz, JA; Romero, A; Sacristán, A; Villamayor, F | 1 |
| Agut, J; Ortiz, JA; Sacristán, A; Sánchez, JC | 1 |
| Conejo, L; Ortiz, JA; Palop, D; Romero, A; Sacristán, A; Villamayor, F | 1 |
| Ballesta, A; Gómez, F; Ortiz, JA; Romero, A; Sacristán, A; Villamayor, F | 1 |
| Agúndez, JA; Albet, C; Benítez, J; Carrillo, JA; Herrero, E; Márquez, M; Martínez, C; Ortiz, JA | 1 |
1 review(s) available for cimetidine and ebrotidine
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
1 trial(s) available for cimetidine and ebrotidine
| Article | Year |
|---|---|
Comparative in vitro and in vivo inhibition of cytochrome P450 CYP1A2, CYP2D6, and CYP3A by H2-receptor antagonists.
Topics: Adult; Anti-Anxiety Agents; Antitussive Agents; Aryl Hydrocarbon Hydroxylases; Benzenesulfonates; Caffeine; Central Nervous System Stimulants; Cimetidine; Cytochrome P-450 CYP1A2 Inhibitors; Cytochrome P-450 CYP2D6 Inhibitors; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme Inhibitors; Dextromethorphan; Double-Blind Method; Histamine H2 Antagonists; Humans; In Vitro Techniques; Male; Methylation; Microsomes, Liver; Midazolam; Oxidoreductases, N-Demethylating; Psychomotor Performance; Ranitidine; Thiazoles | 1999 |
5 other study(ies) available for cimetidine and ebrotidine
| Article | Year |
|---|---|
FDA-approved drug labeling for the study of drug-induced liver injury.
Topics: Animals; Benchmarking; Biomarkers, Pharmacological; Chemical and Drug Induced Liver Injury; Drug Design; Drug Labeling; Drug-Related Side Effects and Adverse Reactions; Humans; Pharmaceutical Preparations; Reproducibility of Results; United States; United States Food and Drug Administration | 2011 |
Effect of ebrotidine on the density of antral G-cells in the gastric mucosa in the rat.
Topics: Animals; Benzenesulfonates; Cell Count; Cell Division; Cimetidine; Gastric Mucosa; Histamine H2 Antagonists; Immunohistochemistry; Male; Pyloric Antrum; Rats; Rats, Sprague-Dawley; Thiazoles | 1995 |
Action of ebrotidine, ranitidine and cimetidine on the specific binding to histamine H1- and H2-receptors.
Topics: Animals; Benzenesulfonates; Cell Membrane; Cerebellum; Cerebral Cortex; Cimetidine; Depression, Chemical; Guinea Pigs; Histamine H2 Antagonists; In Vitro Techniques; Isotope Labeling; Male; Protein Binding; Pyrilamine; Ranitidine; Receptors, Histamine H1; Receptors, Histamine H2; Thiazoles; Tritium | 1997 |
Effect of ebrotidine on ethanol-induced gastric mucosal damage in the rat. Comparative study with other H2-receptor antagonists.
Topics: Animals; Benzenesulfonates; Cimetidine; Dose-Response Relationship, Drug; Ethanol; Famotidine; Female; Gastric Mucosa; Histamine H2 Antagonists; Indomethacin; Peptic Ulcer; Ranitidine; Rats; Rats, Sprague-Dawley; Thiazoles | 1997 |
Comparative study of plasma gastrin levels in rats after two months of ebrotidine administration.
Topics: Animals; Benzenesulfonates; Cimetidine; Gastrins; Histamine H2 Antagonists; Male; Omeprazole; Ranitidine; Rats; Rats, Sprague-Dawley; Specific Pathogen-Free Organisms; Thiazoles | 1997 |